The Hartford Healthcare Fund Class R4
HGHSX
NASDAQ
Weiss Ratings | HGHSX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Fair | |||
Reward Grade | C | |||
Risk Index | Fair | |||
Risk Grade | C | |||
Company Info | HGHSX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Provider | Hartford Mutual Funds | |||
Manager/Tenure (Years) | Rebecca Sykes (4) | |||
Website | http://www.hartfordfunds.com | |||
Fund Information | HGHSX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Fund Name | The Hartford Healthcare Fund Class R4 | |||
Category | Health | |||
Sub-Category | Healthcare Sector Equity | |||
Prospectus Objective | Specialty - Health | |||
Inception Date | Dec 22, 2006 | |||
Open/Closed To New Investors | Open | |||
Minimum Initial Investment | 0.00 | |||
Minimum Subsequent Investment | -- | |||
Front End Fee | -- | |||
Back End Fee | -- | |||
Dividends and Shares | HGHSX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Yield | 0.00% | |||
Dividend | HGHSX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Yield (Forward) | 1.21% | |||
Asset Allocation | HGHSX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash | 2.25% | |||
Stock | 97.75% | |||
U.S. Stock | 90.58% | |||
Non-U.S. Stock | 7.17% | |||
Bond | 0.00% | |||
U.S. Bond | 0.00% | |||
Non-U.S. Bond | 0.00% | |||
Preferred | 0.00% | |||
Convertible | 0.00% | |||
Other Net | 0.00% | |||
Price History | HGHSX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | 1.79% | |||
30-Day Total Return | 2.67% | |||
60-Day Total Return | -2.81% | |||
90-Day Total Return | -6.05% | |||
Year to Date Total Return | -5.45% | |||
1-Year Total Return | -11.75% | |||
2-Year Total Return | -2.24% | |||
3-Year Total Return | 4.06% | |||
5-Year Total Return | 13.50% | |||
Price | HGHSX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Closing Price | -- | |||
1-Month Low Price | -- | |||
1-Month High Price | -- | |||
52-Week Low Price | -- | |||
52-Week Low Price (Date) | -- | |||
52-Week High Price | -- | |||
52-Week High Price (Date) | -- | |||
NAV | HGHSX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Nav | $36.91 | |||
1-Month Low NAV | $35.95 | |||
1-Month High NAV | $37.44 | |||
52-Week Low NAV | $35.40 | |||
52-Week Low NAV (Date) | May 14, 2025 | |||
52-Week High NAV | $47.56 | |||
52-Week High Price (Date) | Aug 30, 2024 | |||
Beta / Standard Deviation | HGHSX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 0.58 | |||
Standard Deviation | 14.23 | |||
Balance Sheet | HGHSX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Total Assets | 796.39M | |||
Operating Ratios | HGHSX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Expense Ratio | 1.31% | |||
Turnover Ratio | 40.00% | |||
Performance | HGHSX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Last Bull Market Total Return | 4.16% | |||
Last Bear Market Total Return | -9.58% | |||